Skip to main content
logo
CF PharmTech, Inc. (HKG:2652)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
19.87
+4.17 (26.56%)
Jul 31, 2026, 4:08 PM HKT

CF PharmTech Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
432.52432.52607.75556.42349.1341.99
Revenue Growth
23.89%-28.83%9.22%59.38%731.54%764.11%
Gross Profit
327.94327.94491.37454.57265.6720.2
Operating Income
-20.15-20.153.542.17-85.78-217.9
Net Income
2.492.4921.0931.73-49.4-131.73
Earnings Per Share
0.010.010.060.09-0.13-
EPS Growth
--88.43%-33.53%---

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
656.22656.22352.1406.96316.79384.73
Total Debt
145.56145.5679.121.911.51.44
Net Cash (Debt)
510.66510.66273.01385.05315.28383.29
Net Cash Growth
61.97%87.05%-29.10%22.13%-17.74%-38.42%
Net Cash Per Share
1.351.350.741.040.85-

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-110.3-110.396.46116.2945.47-156.69
Capital Expenditures
-112.66-112.66-167.66-114.64-91.19-91.25
Free Cash Flow
-222.96-222.96-71.21.65-45.72-247.95
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
75.82%75.82%80.85%81.69%76.09%48.12%
Operating Margin
-4.66%-4.66%0.58%0.39%-24.57%-518.98%
Pretax Margin
-3.10%-3.10%3.16%4.03%-20.23%-462.53%
Profit Margin
0.57%0.57%3.47%5.70%-14.15%-313.74%
FCF Margin
-51.55%-51.55%-11.72%0.30%-13.10%-590.55%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
2950.195213.44----
PS Ratio
16.9529.95----